Filament Health Corp (FH) - Total Liabilities

Latest as of March 2025: CA$1.94 Million CAD ≈ $1.40 Million USD

Based on the latest financial reports, Filament Health Corp (FH) has total liabilities worth CA$1.94 Million CAD (≈ $1.40 Million USD) as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore FH operating cash flow to assess how effectively this company generates cash.

Filament Health Corp - Total Liabilities Trend (2020–2024)

This chart illustrates how Filament Health Corp's total liabilities have evolved over time, based on quarterly financial data. See FH book value for net asset value and shareholders' equity analysis.

Filament Health Corp Competitors by Total Liabilities

The table below lists competitors of Filament Health Corp ranked by their total liabilities.

Company Country Total Liabilities
DMC Mining Ltd
AU:DMM
Australia AU$1.55 Million
Radaan Mediaworks India Limited
NSE:RADAAN
India Rs220.99 Million
RBR Group Ltd
AU:RBR
Australia AU$2.08 Million
Young & Co.'s Brewery P.L.C
LSE:YNGN
UK GBX519.70 Million
BT Wealth Industries Public Company Limited
BK:BTW
Thailand ฿449.79 Million
Silly Monks Entertainment Limited
NSE:SILLYMONKS
India Rs42.12 Million

Liability Composition Analysis (2020–2024)

This chart breaks down Filament Health Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Filament Health Corp.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.16 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.99 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.67 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Filament Health Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Filament Health Corp (2020–2024)

The table below shows the annual total liabilities of Filament Health Corp from 2020 to 2024.

Year Total Liabilities Change
2024-12-31 CA$1.66 Million
≈ $1.20 Million
-46.02%
2023-12-31 CA$3.08 Million
≈ $2.23 Million
+99.35%
2022-12-31 CA$1.55 Million
≈ $1.12 Million
+19.99%
2021-12-31 CA$1.29 Million
≈ $932.83K
+1798.69%
2020-12-31 CA$67.92K
≈ $49.13K
--

About Filament Health Corp

NEO:FH Canada
Market Cap
$1.89 Million
CA$2.62 Million CAD
Market Cap Rank
#29743 Global
#1508 in Canada
Share Price
CA$0.01
Change (1 day)
-33.33%
52-Week Range
CA$0.01 - CA$0.03
All Time High
CA$0.40
About

Filament Health Corp. operates as a clinical-stage natural psychedelic drug development company in Canada. The company's leading drug candidates comprises PEX010 oral psilocybin, PEX020 oral psilocin, and PEX030 sublingual psilocin. It also develops AEX010 ayahuasca, which is in preclinical stage; and AEX020 monoamine oxidase inhibitor and is in preclinical stage. In addition, the company provide… Read more